Earlier this month the FDA approved Keytruda, manufactured by Merck, to treat melanoma. Keytruda disrupts the cancer cells that tell the body's immune system not to attack the cancer cells as intruders. Keytruda, and other drugs in this class are already being tested...
New class of cancer drug, Keytruda offers hope for lung cancer and mesothelioma patients
read more